Future strategies toward the cure of indolent B-cell malignancies: introduction.
Cheson
B D
BD
Medicine Section, Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892, USA.
D001402:B-Lymphocytes / Q000473:pathology*; D005544:Forecasting; D019337:Hematologic Neoplasms / Q000628:therapy*; D006801:Humans